Company / Operating Cash Flow per Share
Editas Medicine, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.54
FY2025
5-year range
-$2.63 / -$0.65
FY2021-FY2025
Trend
-17.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 8 years, ranging from $-2.63 in FY2022 to $-0.19 in FY2019.
Based on SEC 10-K filings.
-2.54 in FY2025.
Declined from $-2.38 to $-2.54 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 17.2% year-over-year.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.54 | -17.2% |
| FY2024 | -$2.17 | +8.8% |
| FY2023 | -$2.38 | +9.5% |
| FY2022 | -$2.63 | -304.3% |
| FY2021 | -$0.65 | +22.7% |
| FY2020 | -$0.84 | -335.4% |
| FY2019 | -$0.19 | +82.9% |
| FY2018 | -$1.13 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026